P&K Skin Research Center Co (347740) Fair Value & Analysis
Healthcare · KR · Market cap 56.0B KRW
Fair value as of: Jun 24, 2026
Analysis
P&K Skin Research Center Co (347740) currently trades at 1,719 KRW, while our model-based Fair Value estimate is 2,835 KRW — implying the stock looks roughly 64.9% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.
About the company
P&K Skin Research Center Co., Ltd. engages in the evaluation and research of dermatological products in South Korea. It provides scientific information and technical support services for new cosmetic raw material development, functional cosmetics, and human application testing of quasi-drugs. The company performs human application, safety, efficacy, cosmeceuticals, health food, sensory, and in vitro tests. It also manufactures and sells raw pharmaceutical and cosmetic materials, and raw materials for health foods. The company was founded in 2010 and is headquartered in Seoul, South Korea. P&K Skin Research Center Co., Ltd. is a subsidiary of Daebongls.Co.,Ltd.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is P&K Skin Research Center Co (347740) undervalued?
What is the fair value of 347740?
What is the quality score of 347740?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.